載入...
Real-world Evaluation of Ceftolozane/Tazobactam (C/T) Use and Clinical Outcomes at an Academic Medical Center in Las Vegas
BACKGROUND: There is a global increase in Gram-negative (GN) pathogens, with Enterobacteriaceae and Pseudomonas aeruginosa(PSA) being the major threats in clinical practice. C/T is a novel antipseudomonal cephalosporin combined with an established β-lactamase inhibitor, approved for the treatment of...
Na minha lista:
發表在: | Open Forum Infect Dis |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632114/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.682 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|